NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
February 15, 2021
A drug being developed by Cary-based Rescindo Therapeutics for treating a rare developmental disorder in children has received two special designations from the FDA.
February 15, 2021
Life sciences manufacturing companies in North Carolina expanded their collective workforce by more than 11%.in 2020, in sharp contrast to the global economic downturn wrought by the COVID-19 pandemic.
February 15, 2021
RTP's G1 Therapeutics has received FDA approval of its first drug, for protecting bone marrow from chemotherapy damage.
February 12, 2021
Veteran pharmaceutical company executive Machelle Sanders, a North Carolina native and former board member of the North Carolina Biotechnology Center, was named Secretary of the Department of Commerce today by Governor Roy Cooper.
February 12, 2021
NC IDEA is welcoming entrepreneurs statewide to submit MICRO and SEED Grant applications until March 1.
February 11, 2021
Medical device maker Bioventus is the latest North Carolina life sciences firm joining the public markets, raising $104 million from its initial public offering.
February 10, 2021
A $1.5 million gift from the North Carolina GlaxoSmithKline Foundation will help community college students pursue science, technology, engineering and math (STEM) degrees at North Carolina Agricultural and Technical State University in Greensboro.
February 10, 2021
Durham's Spencer Health Solutions is striking up alliances with pharma companies, using its smart medication dispensing technology to monitor how patients take their drugs at home while also providing the drug makers insight about how the medicines in clinical testing are working.
February 9, 2021
Durham-based Heat Biologics reported positive interim results from a phase 2 clinical trial of its therapy to treat advanced non-small cell lung cancer.
February 9, 2021
Gov. Roy Cooper announced today that California-based biopharmaceutical company Gilead Sciences, Inc. (Nasdaq; GILD), will invest up to $5 million to establish a 275-employee business services and information technology hub in Wake County.
February 8, 2021
The Golden LEAF Foundation has awarded nearly $1.9 million to help East Carolina University expand its burgeoning pharmaceutical manufacturing workforce training program.
February 7, 2021
Twenty-nine technology companies across North Carolina – about half of them working in the life sciences – have received One North Carolina program grants totaling $1.5 million.
February 5, 2021
Frost & Sullivan has named Durham’s 410 Medical as the 2021 Entrepreneurial Company of the Year in the global fluid resuscitation devices industry.
February 4, 2021
Pairwise, an agricultural biotechnology company that applies gene-editing techniques to food crops, has raised $90 million in funding as it eyes commercialization of its first product next year.
February 3, 2021
The North Carolina Biotechnology Center awarded 17 grants and loans totaling more than $1.4 million to universities, biosciences companies and other entities in the second quarter of its fiscal year.